Literature DB >> 22795224

Intermediate values of glucose-6-phosphate dehydrogenase.

Michael Kaplan, Nurit Algur, Cathy Hammerman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22795224     DOI： 10.1016/j.jpeds.2012.05.064

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  3 in total

1.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Authors:  M V Relling; E M McDonagh; T Chang; K E Caudle; H L McLeod; C E Haidar; T Klein; L Luzzatto
Journal:  Clin Pharmacol Ther       Date:  2014-05-02       Impact factor: 6.875

2.  Lower reference limits of quantitative cord glucose-6-phosphate dehydrogenase estimated from healthy term neonates according to the Clinical and Laboratory Standards Institute guidelines: a cross sectional retrospective study.

Authors:  Sameer Yaseen Al-Abdi; Amina Suleman Alsaigh; Fahima Lugman Aldawoud; Amal Ali Al Sadiq
Journal:  BMC Pediatr       Date:  2013-09-10       Impact factor: 2.125

3.  Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt.

Authors:  Soheir Abo Elella; Mahaa Tawfik; Naglaa Barseem; Wafaa Moustafa
Journal:  Ann Saudi Med       Date:  2017 Sep-Oct       Impact factor: 1.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.